LLY

1,074.31

-2.78%↓

JNJ

205.46

-1.09%↓

ABBV

226.52

-0.45%↓

UNH

331.66

+0.6%↑

AZN

92.38

-1.06%↓

LLY

1,074.31

-2.78%↓

JNJ

205.46

-1.09%↓

ABBV

226.52

-0.45%↓

UNH

331.66

+0.6%↑

AZN

92.38

-1.06%↓

LLY

1,074.31

-2.78%↓

JNJ

205.46

-1.09%↓

ABBV

226.52

-0.45%↓

UNH

331.66

+0.6%↑

AZN

92.38

-1.06%↓

LLY

1,074.31

-2.78%↓

JNJ

205.46

-1.09%↓

ABBV

226.52

-0.45%↓

UNH

331.66

+0.6%↑

AZN

92.38

-1.06%↓

LLY

1,074.31

-2.78%↓

JNJ

205.46

-1.09%↓

ABBV

226.52

-0.45%↓

UNH

331.66

+0.6%↑

AZN

92.38

-1.06%↓

Search

Perspective Therapeutics Inc

Deschisă

2.34 4.93

Rezumat

Modificarea prețului

24h

Curent

Minim

2.23

Maxim

2.37

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+411.21% upside

Perspective Therapeutics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

27 nov. 2025, 16:49 UTC

Achiziții, Fuziuni, Preluări

Deutsche Boerse in Talks to Buy Fund-Tech Platform Allfunds in $6 Billion Deal

27 nov. 2025, 15:32 UTC

Achiziții, Fuziuni, Preluări

TotalEnergies, Repsol in Talks to Combine U.K. North Sea Assets, Cinco Dias Says, Citing Sources

27 nov. 2025, 23:50 UTC

Market Talk

Nikkei May Trade Rangebound Amid Caution Over Economic Outlook -- Market Talk

27 nov. 2025, 23:50 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

27 nov. 2025, 16:05 UTC

Market Talk

Canadian Job Vacancies Rise for Fist Time Since Start of 2024 -- Market Talk

27 nov. 2025, 16:04 UTC

Market Talk

Canadian Payroll Employment Pulls Back in September, Offsetting Recent Gains -- Market Talk

27 nov. 2025, 15:54 UTC

Achiziții, Fuziuni, Preluări

Allfunds Shares Rise 21% After Deutsche Boerse Says Started Acquisition Talks

27 nov. 2025, 15:44 UTC

Achiziții, Fuziuni, Preluări

Deutsche Boerse: No Certainty Talks Will Result in Transaction

27 nov. 2025, 15:43 UTC

Achiziții, Fuziuni, Preluări

Deutsche Boerse: Allfunds Board of Directors Has Agreed to Enter Exclusive Talks

27 nov. 2025, 15:42 UTC

Achiziții, Fuziuni, Preluări

Deutsche Boerse: Nonbinding Proposal is To Acquire Allfunds at EUR8.80 a Share

27 nov. 2025, 15:41 UTC

Achiziții, Fuziuni, Preluări

Deutsche Boerse in Talks With Allfunds on Possible Acquisition

27 nov. 2025, 15:11 UTC

Market Talk

Dollar Could Fall in 2026 as U.S. Rate Cuts Bite -- Market Talk

27 nov. 2025, 14:26 UTC

Market Talk

Hermes' Outperformance Gap Could Narrow -- Market Talk

27 nov. 2025, 14:11 UTC

Market Talk

Lack of Major Budget Surprises Don't Justify Continued Sterling Strength -- Market Talk

27 nov. 2025, 14:11 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

27 nov. 2025, 13:35 UTC

Market Talk

Richemont Looks Set to Continue Outgrowing Peers -- Market Talk

27 nov. 2025, 13:33 UTC

Market Talk

Sterling's Post-Budget Gains Are Probably Over -- Market Talk

27 nov. 2025, 13:22 UTC

Market Talk

Global Equities Roundup: Market Talk

27 nov. 2025, 13:22 UTC

Market Talk

Kering's Plan to Revive Gucci Needs More Clarity -- Market Talk

27 nov. 2025, 13:17 UTC

Market Talk

LVMH Should Be Able to Recover Next Year -- Market Talk

27 nov. 2025, 11:13 UTC

Market Talk

European Gas Prices Come Under Pressure -- Market Talk

27 nov. 2025, 11:07 UTC

Câștiguri

Genting: Positive About Prospects Over Longer Term

27 nov. 2025, 11:06 UTC

Câștiguri

Genting: Cautious on Near-Term Prospects of Leisure, Hospitality Industry

27 nov. 2025, 11:04 UTC

Câștiguri

Genting: International Travel Demand Expected to Remain Resilient

27 nov. 2025, 11:04 UTC

Câștiguri

Genting: Global Growth Expected to Remain Subdued

27 nov. 2025, 11:04 UTC

Câștiguri

Genting: Ebitda Partly Weighed by Stronger Ringgit Vs. Singapore Dollar, British Pound, U.S. Dollar

27 nov. 2025, 10:59 UTC

Câștiguri

Genting Bhd 3Q Net Profit Fell 86% on Year

27 nov. 2025, 10:58 UTC

Câștiguri

Genting Bhd 3Q Rev Rose 14% on Year

27 nov. 2025, 10:56 UTC

Câștiguri

Genting Bhd 3Q Net MYR30.3M

27 nov. 2025, 10:56 UTC

Câștiguri

Genting Bhd 3Q EPS MYR0.0079

Comparație

Modificare preț

Perspective Therapeutics Inc Așteptări

Obiectiv de preț

By TipRanks

411.21% sus

Prognoză pe 12 luni

Medie 11.4 USD  411.21%

Maxim 18 USD

Minim 5 USD

În baza a 10 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruPerspective Therapeutics Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

10 ratings

9

Cumpărare

1

Păstrare

0

Vânzare

Date financiare

$

help-icon Live chat